APA (7th ed.) Citation

Irena E. Belousova, Liliya G. Gorenkova, Sergei K. Kravchenko, Alla M. Kovrigina, Elena E. Lepik, & Tatiana V. Shneyder. (2022). Efficacy of brentuximab vedotin in patients with CD30-positive lymphoproliferative skin diseases: Results of the first prospective study in the Russian Federation. State Scientific Center of Dermatovenereology and Cosmetology.

Chicago Style (17th ed.) Citation

Irena E. Belousova, Liliya G. Gorenkova, Sergei K. Kravchenko, Alla M. Kovrigina, Elena E. Lepik, and Tatiana V. Shneyder. Efficacy of Brentuximab Vedotin in Patients with CD30-positive Lymphoproliferative Skin Diseases: Results of the First Prospective Study in the Russian Federation. State Scientific Center of Dermatovenereology and Cosmetology, 2022.

MLA (9th ed.) Citation

Irena E. Belousova, et al. Efficacy of Brentuximab Vedotin in Patients with CD30-positive Lymphoproliferative Skin Diseases: Results of the First Prospective Study in the Russian Federation. State Scientific Center of Dermatovenereology and Cosmetology, 2022.